Robert Sheldon Epstein MD
Public Health & General Preventive Medicine
Chairman of Board of Directors - Veracyte Member, Boards of Directors - Illumina, Fate Therapeutics, Diadem, PinkDx, Tasso, Estonian Multi-omics Company
Join to View Full Profile
75 Tweed BlvdNyack, NY 10960
Phone+1 845-680-0461
Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Epstein is a chronic disease epidemiologist board certified in Preventive Medicine, based in Nyack, NY. He graduated from the University of Michigan Medical School in 1979. After a brief stint in academia, he entered the corporate sector initially as a medical researcher, advancing to lead the acquisition and subsequently run a 2200 employee global company servicing the biopharma industry. In recent years, RE has served on numerous Boards of Directors of private and public companies, and has taken several public along with continuing research activities, co-authoring >150 articles in peer-reviewed medical journals.
Education & Training
University of Michigan Medical SchoolClass of 1979
Certifications & Licensure
NY State Medical License 1981 - 2026
FL State Medical License 2016 - 2018
PA State Medical License 1980 - 2004
MD State Medical License 1986 - 1990
American Board of Preventive Medicine Public Health & General Preventive Medicine
Publications & Presentations
PubMed
- 1 citationsPlain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane
Future Oncology. 2024-01-01 - 3 citationsPatients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.Amer M Zeidan, Kate Perepezko, Tehseen Salimi, Terri Washington, Robert S Epstein
Therapeutic Advances in Hematology. 2024-01-01 - 3 citationsImpact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.Amer M Zeidan, Namita Joshi, Hrishikesh Kale, Wei-Jhih Wang, Shelby Corman
Clinical Lymphoma, Myeloma & Leukemia. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
